These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19884127)

  • 1. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
    Jensen A; Sharif H; Kjaer SK
    Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine cancer after use of clomiphene citrate to induce ovulation.
    Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
    Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Cancer Causes Control; 2008 Sep; 19(7):759-65. PubMed ID: 18340541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
    Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
    Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
    Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
    Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
    Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk associated with ovulation-stimulating drugs.
    Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
    Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women.
    Jensen A; Sharif H; Olsen JH; Kjaer SK
    Am J Epidemiol; 2008 Jul; 168(1):49-57. PubMed ID: 18448441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.
    Skalkidou A; Sergentanis TN; Gialamas SP; Georgakis MK; Psaltopoulou T; Trivella M; Siristatidis CS; Evangelou E; Petridou E
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010931. PubMed ID: 28349511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
    Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
    Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood tumor risk after treatment with ovulation-stimulating drugs.
    Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
    Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cholecystitis in patients with cancer: a population-based cohort study in Denmark.
    Thomsen RW; Thomsen HF; Nørgaard M; Cetin K; McLaughlin JK; Tarone RE; Fryzek JP; Sørensen HT
    Cancer; 2008 Dec; 113(12):3410-9. PubMed ID: 18951518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer after successful ovulation induction: a case report.
    Hull ME; Kriner M; Schneider E; Maiman M
    J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
    Kashyap S; Moher D; Fung MF; Rosenwaks Z
    Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study.
    Baldur-Felskov B; Kjaer SK; Albieri V; Steding-Jessen M; Kjaer T; Johansen C; Dalton SO; Jensen A
    Hum Reprod; 2013 Mar; 28(3):683-90. PubMed ID: 23223399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study.
    Gauthier E; Paoletti X; Clavel-Chapelon F;
    Hum Reprod; 2004 Oct; 19(10):2216-21. PubMed ID: 15271872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular telephone use and cancer risk: update of a nationwide Danish cohort.
    Schüz J; Jacobsen R; Olsen JH; Boice JD; McLaughlin JK; Johansen C
    J Natl Cancer Inst; 2006 Dec; 98(23):1707-13. PubMed ID: 17148772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.